TD Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-157,892
Closed -$27.2M 1581
2021
Q3
$27.2M Buy
157,892
+15,151
+11% +$2.61M 0.03% 403
2021
Q2
$17.9M Buy
142,741
+3,711
+3% +$464K 0.02% 504
2021
Q1
$18.9M Buy
139,030
+13,528
+11% +$1.83M 0.02% 481
2020
Q4
$16.1M Buy
125,502
+9,274
+8% +$1.19M 0.02% 481
2020
Q3
$13.1M Buy
116,228
+13,460
+13% +$1.51M 0.02% 485
2020
Q2
$9.79M Buy
102,768
+12,807
+14% +$1.22M 0.01% 516
2020
Q1
$8.09M Buy
89,961
+10,053
+13% +$903K 0.01% 526
2019
Q4
$4.24M Sell
79,908
-2,700
-3% -$143K 0.01% 751
2019
Q3
$3.26M Sell
82,608
-1,200
-1% -$47.4K 0.01% 788
2019
Q2
$3.44M Sell
83,808
-18,794
-18% -$772K 0.01% 780
2019
Q1
$4.78M Sell
102,602
-16,319
-14% -$760K 0.01% 704
2018
Q4
$5.18M Buy
118,921
+10,900
+10% +$475K 0.01% 650
2018
Q3
$6.18M Buy
108,021
+19,321
+22% +$1.11M 0.01% 666
2018
Q2
$4.3M Buy
88,700
+16,000
+22% +$776K 0.01% 756
2018
Q1
$2.84M Buy
72,700
+11,200
+18% +$438K ﹤0.01% 812
2017
Q4
$2.61M Hold
61,500
﹤0.01% 828
2017
Q3
$2.3M Sell
61,500
-17,300
-22% -$646K ﹤0.01% 837
2017
Q2
$2.4M Buy
78,800
+600
+0.8% +$18.2K ﹤0.01% 834
2017
Q1
$2.07M Buy
78,200
+5,200
+7% +$138K ﹤0.01% 880
2016
Q4
$1.86M Buy
73,000
+8,000
+12% +$204K ﹤0.01% 877
2016
Q3
$2.35M Buy
65,000
+3,000
+5% +$109K ﹤0.01% 847
2016
Q2
$2.11M Buy
62,000
+900
+1% +$30.6K ﹤0.01% 849
2016
Q1
$1.61M Sell
61,100
-2,000
-3% -$52.8K ﹤0.01% 872
2015
Q4
$3.08M Buy
63,100
+500
+0.8% +$24.4K 0.01% 767
2015
Q3
$1.56M Buy
62,600
+700
+1% +$17.4K ﹤0.01% 852
2015
Q2
$1.96M Sell
61,900
-1,500
-2% -$47.5K ﹤0.01% 859
2015
Q1
$2.41M Buy
63,400
+6,500
+11% +$247K ﹤0.01% 809
2014
Q4
$2.22M Buy
56,900
+1,500
+3% +$58.4K ﹤0.01% 826
2014
Q3
$1.68M Sell
55,400
-400
-0.7% -$12.1K ﹤0.01% 848
2014
Q2
$1.9M Buy
55,800
+24,600
+79% +$836K ﹤0.01% 833
2014
Q1
$1.08M Buy
31,200
+20,100
+181% +$693K ﹤0.01% 899
2013
Q4
$440K Buy
+11,100
New +$440K ﹤0.01% 1053